Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 16, Number 2—February 2010


Risk Factors for and Estimated Incidence of Community-associated Clostridium difficile Infection, North Carolina, USA1

CME Logo


MedscapeCME is pleased to provide online continuing medical education (CME) for this journal article, allowing clinicians the opportunity to earn CME credit. This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of MedscapeCME and Emerging Infectious Diseases. MedscapeCME is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. MedscapeCME designates this educational activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation at; (4) view/print certificate.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Specify the prevalence of community-acquired Clostridium difficile infection

  • Describe demographic trends in community-acquired C. difficile infection

  • Identify case characteristics of C. difficile infection

  • List risk factors for community-acquired C. difficile infection


Nancy Mannikko, PhD, MS, BS, Copyeditor, Emerging Infectious Diseases. Disclosure: Nancy Mannikko, PhD, MS, BS, has disclosed no relevant financial relationships.


Charles P. Vega, MD, Associate Professor, Residency Director, Department of Family Medicine, University of California, Irvine, California, USA. Disclosure: Charles P. Vega, MD, has disclosed no relevant financial relationships.


Disclosures: Preeta K. Kutty, MD, MPH; Arlene C. Sena, MD, MPH; Stephen R. Benoit, MD, MPH; Susanna Naggie, MD; Joyce Frederick, MSN; Sharon Evans, RN; Jeffery Engel, MD; and L. Clifford McDonald, MD, have disclosed no relevant financial relationships. Christopher W. Woods, MD, MPH, has disclosed the following relevant financial relationships: served as an advisor or consultant for Cepheid Diagnostics, Roche Molecular, and bioMérieux; received grants for clinical research from Cepheid Diagnostics, Roche Molecular, bioMérieux, Cubist Pharmaceuticals, and Theravance Pharmaceuticals.


Article Navigation